| Nov 18 |
Eli Lilly follows J&J in suing Biden administration over 340B rebates
|
| Nov 18 |
Eli Lilly reports outcomes from Phase III trial of tirzepatide for HFpEF
|
| Nov 17 |
If You Bought 1 Share of Eli Lilly in 1984, Here's How Many Shares You Would Own Now
|
| Nov 17 |
Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth
|
| Nov 17 |
Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready to Meet Demand?
|
| Nov 17 |
Prediction: 3 Stocks That'll Be Worth More Than Tesla 10 Years From Now
|
| Nov 16 |
Lilly's tirzepatide reduced the risk of worsening heart failure events by 38% in adults with heart failure with preserved ejection fraction (HFpEF) and obesity
|
| Nov 16 |
The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
|
| Nov 15 |
Large pharmas, biotechs down as industries grapple with RFK Jr. at HHS
|
| Nov 15 |
U.S. Pharma is largely immune from 'MAHA' impact: Wolfe
|
